 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/11/2025 |
$14.17 |
$14.61 |
$13.73 |
$14.58 |
1.90M | | 04/14/2025 |
$14.86 |
$15.00 |
$14.45 |
$14.86 |
1.22M | | 04/15/2025 |
$14.77 |
$15.18 |
$14.77 |
$14.99 |
1.06M | | 04/16/2025 |
$14.88 |
$14.88 |
$14.34 |
$14.57 |
1.15M | | 04/17/2025 |
$14.47 |
$14.75 |
$14.39 |
$14.73 |
1.21M |
|
|
| Acadia Pharmaceuticals Inc. is a biopharmaceutical company. Co. is focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has a portfolio of commercial stage products, in-development product opportunities, and research programs that are designed to address unmet needs in CNS disorders and rare diseases. Its pipeline includes NUPLAZID (pimavanserin), DAYBUE (trofinetide), ACP-101, ACP-204, and Antisense Oligonucleotide (ASO) Programs. NUPLAZID is a selective serotonin inverse agonist/antagonist preferentially targeting the 5-HT2A receptor. | |
|
Acadia Pharmaceuticals (ACAD) has the following price history information. Looking back at ACAD historical stock prices for the last five trading days, on April 11, 2025, ACAD opened at $14.17, traded as high as $14.61 and as low as $13.73, and closed at $14.58. Trading volume was a total of 1.90M shares. On April 14, 2025, ACAD opened at $14.86, traded as high as $15.00 and as low as $14.45, and closed at $14.86. Trading volume was a total of 1.22M shares. On April 15, 2025, ACAD opened at $14.77, traded as high as $15.18 and as low as $14.77, and closed at $14.99. Trading volume was a total of 1.06M shares. On April 16, 2025, ACAD opened at $14.88, traded as high as $14.88 and as low as $14.34, and closed at $14.57. Trading volume was a total of 1.15M shares. On April 17, 2025, ACAD opened at $14.47, traded as high as $14.75 and as low as $14.39, and closed at $14.73. Trading volume was a total of 1.21M shares.
ACAD Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Acadia Pharmaceuticals shares, starting with a $10,000 purchase of ACAD, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/21/2015 |
|
| End date: |
04/17/2025 |
|
| Start price/share: |
$38.75 |
|
| End price/share: |
$14.73 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-61.99% |
|
| Average Annual Total Return: |
-9.22% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$3,802.04 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 04/11/2025 | $14.58 | | 04/14/2025 | $14.86 | | 04/15/2025 | $14.99 | | 04/16/2025 | $14.57 | | 04/17/2025 | $14.73 |
|
|
Free ACAD Email Alerts:
